Company Profile

The information below does not constitute any invitation or offer to sell, invest in or trade, nor does it constitute any invitation to place any offer to purchase, invest in or trade the securities. The information presented herein is up to date as on the date of publication. For more information, please contact Investor Relations Centre, tel: (+48 22) 695 90 01-02, e-mail: investor@msp.gov.pl.

Cefarm Rzeszów S.A. seated in Rzeszów

Description of activity

The principal activity of the Company is retail trade in the sector of pharmaceutical products. The Company sells its products to individual customers. The basic market for the Company's products is podkarpackie region. The Company conducts the sale of its products via its own pjarmacy chain (47 pharmacies and 1 herbal store). The main supplier with which the Company cooperates is Cefarm Rzeszów Sp. z o. o., in which Cefarm Rzeszów S.A. holds 100% of the shares. The Company is a member of Grupa Kapitałowa ACP Pharma, whose other members are ACP Pharma S.A., Cefarm Śląski Katowice S.A. and Cefarm Zielona Góra S.A. The Company's strategy envisages its participation in Grupa Kapitałowa ACP Pharma's projects through, among others, establishing a common loyalty programme. The Company's strategic objective is to retain its leading position and to concentrate on the podkarpackie market.

Contact information

Province : podkarpackie

Cefarm Rzeszów S.A.
Chmaja 6
35-021 Rzeszów
ph.: (+48 17) 865 03 00
fax: (+48 17) 865 04 65
www.cefarm.rzeszow.pl

Ministry of Treasury
ul. Krucza 36 / Wspólna 6
00-522 Warszawa
Department of Privatisation
ph.: (+48 22) 695 87 22, 695 87 05
fax: (+48 22) 695 88 18
Investor Realtions Centre
ph.: (+48 22) 695 90 01
ph.: (+48 22) 695 90 02
fax: (+48 22) 629 98 38
investor@msp.gov.pl
www.msp.gov.pl

foto

Performance in thousand PLN

 
 
2008
2009
2010
Sales revenue
118 122.0
120 194.0
121 697.0
EBITDA
6 322.0
7 438.0
5 400.0
Net result
3 946.0
 -848.0
3 368.0

Planned privatisation

The Treasury holds 49% of the Company's shares. ACP Pharma is its majority shareholder holding 51% of the shares.

History of privatisation:
Cancellation of a tender: 30 December 2011
Invitation to a public tender. More information
Cancellation of the auction: 24 January 2011
Invitation to participate in the public auction:  More information

Employment

278 employees

Initial capital

PLN 65 479 600.00

President of the Management Board

Wojciech Galemba

Privatisation advisor

-

Drukuj
Poleć stronę
Wstecz
Publication date : 14.01.2010
Modification date : 09.01.2012
Katarzyna Szulc